Kristin Comella is the Chief Executive Officer at Stemlogix LLC, Chief Scientific Officer at Ageless Regenerative Institute, Chief Scientific Officer at Bioheart Inc. She is a leading expert in the clinical and research applications of stem cells. One does not need to use embryonic stem cells (the controversial type) to treat medical conditions. Our own stem cells and specialized ones from others can be used to do that. Such therapies exist now and in the next 5 – 10 years common orthopedic surgeries and the current treatment of many cardiac ailments will be obsolete.